fbpx
    • Life With Multiple Myeloma
    • Jan 14, 2019

    Patient Power: Is Maintenance Therapy Necessary for MRD Negative Patients?

When a multiple myeloma patient achieves a negative MRD test, it doesn’t necessarily mean that the patient is cured, but it does mean that the most sensitive testing available does not detect myeloma–which is a very good thing.

Dr. Gareth Morgan from the UAMS Myeloma Institute noted that this stage is “a very good endpoint…but, it’s not an endpoint that says ‘stop treatment’.”

Several studies, including the ixazomib maintenance data, have shown that even with an MRD negative test, receiving maintenance therapy approves a patient’s outcome even further.

“We have to be thinking about patients’ quality of life, durability of on-going therapy, total cost–but actually, I think within the cost envelope we have now, I think there’s a lot of room for maneuver that really is going to see patients patent that progression for an overall survival pushed out, so very good numbers.” -Dr. Morgan.

See full video.

About Author

MYELOMA CROWD RESEARCH INITIATIVE
$125755 of $500,000 Raised
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal

AmazonSmile

Get Started Today.

Find a Clinical Trial that's Right for You

Go

Thanks to our site sponsors: